Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Personal Care Active Ingredient Market

ID: MRFR/HC/30150-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Active Ingredients in Personal Care Market Research Report By Ingredient Type (Emollients, Humectants, Surfactants, Preservatives, Anti-aging Agents), By Formulation Type (Creams and Lotions, Gels, Serums, Cleansers, Masks), By Application Category (Skin Care, Hair Care, Oral Care, Makeup Products, Suncare), By Functional Properties (Moisturizers, Anti-inflammatory Agents, Antioxidants, UV Filters, Exfoliants), By Source Type (Natural Ingredients, Synthetic Ingredients, Biotech Ingredients) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Personal Care Active Ingredient Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Emollients
  50.     4.1.2 Humectants
  51.     4.1.3 Surfactants
  52.     4.1.4 Preservatives
  53.     4.1.5 Anti-aging Agents
  54.   4.2 Healthcare, BY Formulation Type (USD Billion)
  55.     4.2.1 Creams and Lotions
  56.     4.2.2 Gels
  57.     4.2.3 Serums
  58.     4.2.4 Cleansers
  59.     4.2.5 Masks
  60.   4.3 Healthcare, BY Application Category (USD Billion)
  61.     4.3.1 Skin Care
  62.     4.3.2 Hair Care
  63.     4.3.3 Oral Care
  64.     4.3.4 Makeup Products
  65.     4.3.5 Suncare
  66.   4.4 Healthcare, BY Functional Properties (USD Billion)
  67.     4.4.1 Moisturizers
  68.     4.4.2 Anti-inflammatory Agents
  69.     4.4.3 Antioxidants
  70.     4.4.4 UV Filters
  71.     4.4.5 Exfoliants
  72.   4.5 Healthcare, BY Source Type (USD Billion)
  73.     4.5.1 Natural Ingredients
  74.     4.5.2 Synthetic Ingredients
  75.     4.5.3 Biotech Ingredients
  76.   4.6 Healthcare, BY Region (USD Billion)
  77.     4.6.1 North America
  78.       4.6.1.1 US
  79.       4.6.1.2 Canada
  80.     4.6.2 Europe
  81.       4.6.2.1 Germany
  82.       4.6.2.2 UK
  83.       4.6.2.3 France
  84.       4.6.2.4 Russia
  85.       4.6.2.5 Italy
  86.       4.6.2.6 Spain
  87.       4.6.2.7 Rest of Europe
  88.     4.6.3 APAC
  89.       4.6.3.1 China
  90.       4.6.3.2 India
  91.       4.6.3.3 Japan
  92.       4.6.3.4 South Korea
  93.       4.6.3.5 Malaysia
  94.       4.6.3.6 Thailand
  95.       4.6.3.7 Indonesia
  96.       4.6.3.8 Rest of APAC
  97.     4.6.4 South America
  98.       4.6.4.1 Brazil
  99.       4.6.4.2 Mexico
  100.       4.6.4.3 Argentina
  101.       4.6.4.4 Rest of South America
  102.     4.6.5 MEA
  103.       4.6.5.1 GCC Countries
  104.       4.6.5.2 South Africa
  105.       4.6.5.3 Rest of MEA
  106. 5 SECTION V: COMPETITIVE ANALYSIS
  107.   5.1 Competitive Landscape
  108.     5.1.1 Overview
  109.     5.1.2 Competitive Analysis
  110.     5.1.3 Market share Analysis
  111.     5.1.4 Major Growth Strategy in the Healthcare
  112.     5.1.5 Competitive Benchmarking
  113.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  114.     5.1.7 Key developments and growth strategies
  115.       5.1.7.1 New Product Launch/Service Deployment
  116.       5.1.7.2 Merger & Acquisitions
  117.       5.1.7.3 Joint Ventures
  118.     5.1.8 Major Players Financial Matrix
  119.       5.1.8.1 Sales and Operating Income
  120.       5.1.8.2 Major Players R&D Expenditure. 2023
  121.   5.2 Company Profiles
  122.     5.2.1 BASF SE (DE)
  123.       5.2.1.1 Financial Overview
  124.       5.2.1.2 Products Offered
  125.       5.2.1.3 Key Developments
  126.       5.2.1.4 SWOT Analysis
  127.       5.2.1.5 Key Strategies
  128.     5.2.2 Dow Inc. (US)
  129.       5.2.2.1 Financial Overview
  130.       5.2.2.2 Products Offered
  131.       5.2.2.3 Key Developments
  132.       5.2.2.4 SWOT Analysis
  133.       5.2.2.5 Key Strategies
  134.     5.2.3 Evonik Industries AG (DE)
  135.       5.2.3.1 Financial Overview
  136.       5.2.3.2 Products Offered
  137.       5.2.3.3 Key Developments
  138.       5.2.3.4 SWOT Analysis
  139.       5.2.3.5 Key Strategies
  140.     5.2.4 Croda International Plc (GB)
  141.       5.2.4.1 Financial Overview
  142.       5.2.4.2 Products Offered
  143.       5.2.4.3 Key Developments
  144.       5.2.4.4 SWOT Analysis
  145.       5.2.4.5 Key Strategies
  146.     5.2.5 Ashland Global Holdings Inc. (US)
  147.       5.2.5.1 Financial Overview
  148.       5.2.5.2 Products Offered
  149.       5.2.5.3 Key Developments
  150.       5.2.5.4 SWOT Analysis
  151.       5.2.5.5 Key Strategies
  152.     5.2.6 Solvay SA (BE)
  153.       5.2.6.1 Financial Overview
  154.       5.2.6.2 Products Offered
  155.       5.2.6.3 Key Developments
  156.       5.2.6.4 SWOT Analysis
  157.       5.2.6.5 Key Strategies
  158.     5.2.7 Clariant AG (CH)
  159.       5.2.7.1 Financial Overview
  160.       5.2.7.2 Products Offered
  161.       5.2.7.3 Key Developments
  162.       5.2.7.4 SWOT Analysis
  163.       5.2.7.5 Key Strategies
  164.     5.2.8 Innospec Inc. (US)
  165.       5.2.8.1 Financial Overview
  166.       5.2.8.2 Products Offered
  167.       5.2.8.3 Key Developments
  168.       5.2.8.4 SWOT Analysis
  169.       5.2.8.5 Key Strategies
  170.     5.2.9 Kraton Corporation (US)
  171.       5.2.9.1 Financial Overview
  172.       5.2.9.2 Products Offered
  173.       5.2.9.3 Key Developments
  174.       5.2.9.4 SWOT Analysis
  175.       5.2.9.5 Key Strategies
  176.   5.3 Appendix
  177.     5.3.1 References
  178.     5.3.2 Related Reports
  179. 6 LIST OF FIGURES
  180.   6.1 MARKET SYNOPSIS
  181.   6.2 NORTH AMERICA MARKET ANALYSIS
  182.   6.3 US MARKET ANALYSIS BY TYPE
  183.   6.4 US MARKET ANALYSIS BY FORMULATION TYPE
  184.   6.5 US MARKET ANALYSIS BY APPLICATION CATEGORY
  185.   6.6 US MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  186.   6.7 US MARKET ANALYSIS BY SOURCE TYPE
  187.   6.8 CANADA MARKET ANALYSIS BY TYPE
  188.   6.9 CANADA MARKET ANALYSIS BY FORMULATION TYPE
  189.   6.10 CANADA MARKET ANALYSIS BY APPLICATION CATEGORY
  190.   6.11 CANADA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  191.   6.12 CANADA MARKET ANALYSIS BY SOURCE TYPE
  192.   6.13 EUROPE MARKET ANALYSIS
  193.   6.14 GERMANY MARKET ANALYSIS BY TYPE
  194.   6.15 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
  195.   6.16 GERMANY MARKET ANALYSIS BY APPLICATION CATEGORY
  196.   6.17 GERMANY MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  197.   6.18 GERMANY MARKET ANALYSIS BY SOURCE TYPE
  198.   6.19 UK MARKET ANALYSIS BY TYPE
  199.   6.20 UK MARKET ANALYSIS BY FORMULATION TYPE
  200.   6.21 UK MARKET ANALYSIS BY APPLICATION CATEGORY
  201.   6.22 UK MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  202.   6.23 UK MARKET ANALYSIS BY SOURCE TYPE
  203.   6.24 FRANCE MARKET ANALYSIS BY TYPE
  204.   6.25 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
  205.   6.26 FRANCE MARKET ANALYSIS BY APPLICATION CATEGORY
  206.   6.27 FRANCE MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  207.   6.28 FRANCE MARKET ANALYSIS BY SOURCE TYPE
  208.   6.29 RUSSIA MARKET ANALYSIS BY TYPE
  209.   6.30 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
  210.   6.31 RUSSIA MARKET ANALYSIS BY APPLICATION CATEGORY
  211.   6.32 RUSSIA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  212.   6.33 RUSSIA MARKET ANALYSIS BY SOURCE TYPE
  213.   6.34 ITALY MARKET ANALYSIS BY TYPE
  214.   6.35 ITALY MARKET ANALYSIS BY FORMULATION TYPE
  215.   6.36 ITALY MARKET ANALYSIS BY APPLICATION CATEGORY
  216.   6.37 ITALY MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  217.   6.38 ITALY MARKET ANALYSIS BY SOURCE TYPE
  218.   6.39 SPAIN MARKET ANALYSIS BY TYPE
  219.   6.40 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
  220.   6.41 SPAIN MARKET ANALYSIS BY APPLICATION CATEGORY
  221.   6.42 SPAIN MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  222.   6.43 SPAIN MARKET ANALYSIS BY SOURCE TYPE
  223.   6.44 REST OF EUROPE MARKET ANALYSIS BY TYPE
  224.   6.45 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
  225.   6.46 REST OF EUROPE MARKET ANALYSIS BY APPLICATION CATEGORY
  226.   6.47 REST OF EUROPE MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  227.   6.48 REST OF EUROPE MARKET ANALYSIS BY SOURCE TYPE
  228.   6.49 APAC MARKET ANALYSIS
  229.   6.50 CHINA MARKET ANALYSIS BY TYPE
  230.   6.51 CHINA MARKET ANALYSIS BY FORMULATION TYPE
  231.   6.52 CHINA MARKET ANALYSIS BY APPLICATION CATEGORY
  232.   6.53 CHINA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  233.   6.54 CHINA MARKET ANALYSIS BY SOURCE TYPE
  234.   6.55 INDIA MARKET ANALYSIS BY TYPE
  235.   6.56 INDIA MARKET ANALYSIS BY FORMULATION TYPE
  236.   6.57 INDIA MARKET ANALYSIS BY APPLICATION CATEGORY
  237.   6.58 INDIA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  238.   6.59 INDIA MARKET ANALYSIS BY SOURCE TYPE
  239.   6.60 JAPAN MARKET ANALYSIS BY TYPE
  240.   6.61 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
  241.   6.62 JAPAN MARKET ANALYSIS BY APPLICATION CATEGORY
  242.   6.63 JAPAN MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  243.   6.64 JAPAN MARKET ANALYSIS BY SOURCE TYPE
  244.   6.65 SOUTH KOREA MARKET ANALYSIS BY TYPE
  245.   6.66 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
  246.   6.67 SOUTH KOREA MARKET ANALYSIS BY APPLICATION CATEGORY
  247.   6.68 SOUTH KOREA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  248.   6.69 SOUTH KOREA MARKET ANALYSIS BY SOURCE TYPE
  249.   6.70 MALAYSIA MARKET ANALYSIS BY TYPE
  250.   6.71 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
  251.   6.72 MALAYSIA MARKET ANALYSIS BY APPLICATION CATEGORY
  252.   6.73 MALAYSIA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  253.   6.74 MALAYSIA MARKET ANALYSIS BY SOURCE TYPE
  254.   6.75 THAILAND MARKET ANALYSIS BY TYPE
  255.   6.76 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
  256.   6.77 THAILAND MARKET ANALYSIS BY APPLICATION CATEGORY
  257.   6.78 THAILAND MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  258.   6.79 THAILAND MARKET ANALYSIS BY SOURCE TYPE
  259.   6.80 INDONESIA MARKET ANALYSIS BY TYPE
  260.   6.81 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
  261.   6.82 INDONESIA MARKET ANALYSIS BY APPLICATION CATEGORY
  262.   6.83 INDONESIA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  263.   6.84 INDONESIA MARKET ANALYSIS BY SOURCE TYPE
  264.   6.85 REST OF APAC MARKET ANALYSIS BY TYPE
  265.   6.86 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
  266.   6.87 REST OF APAC MARKET ANALYSIS BY APPLICATION CATEGORY
  267.   6.88 REST OF APAC MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  268.   6.89 REST OF APAC MARKET ANALYSIS BY SOURCE TYPE
  269.   6.90 SOUTH AMERICA MARKET ANALYSIS
  270.   6.91 BRAZIL MARKET ANALYSIS BY TYPE
  271.   6.92 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
  272.   6.93 BRAZIL MARKET ANALYSIS BY APPLICATION CATEGORY
  273.   6.94 BRAZIL MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  274.   6.95 BRAZIL MARKET ANALYSIS BY SOURCE TYPE
  275.   6.96 MEXICO MARKET ANALYSIS BY TYPE
  276.   6.97 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
  277.   6.98 MEXICO MARKET ANALYSIS BY APPLICATION CATEGORY
  278.   6.99 MEXICO MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  279.   6.100 MEXICO MARKET ANALYSIS BY SOURCE TYPE
  280.   6.101 ARGENTINA MARKET ANALYSIS BY TYPE
  281.   6.102 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
  282.   6.103 ARGENTINA MARKET ANALYSIS BY APPLICATION CATEGORY
  283.   6.104 ARGENTINA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  284.   6.105 ARGENTINA MARKET ANALYSIS BY SOURCE TYPE
  285.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  286.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
  287.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION CATEGORY
  288.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  289.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY SOURCE TYPE
  290.   6.111 MEA MARKET ANALYSIS
  291.   6.112 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  292.   6.113 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
  293.   6.114 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION CATEGORY
  294.   6.115 GCC COUNTRIES MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  295.   6.116 GCC COUNTRIES MARKET ANALYSIS BY SOURCE TYPE
  296.   6.117 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  297.   6.118 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
  298.   6.119 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION CATEGORY
  299.   6.120 SOUTH AFRICA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  300.   6.121 SOUTH AFRICA MARKET ANALYSIS BY SOURCE TYPE
  301.   6.122 REST OF MEA MARKET ANALYSIS BY TYPE
  302.   6.123 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
  303.   6.124 REST OF MEA MARKET ANALYSIS BY APPLICATION CATEGORY
  304.   6.125 REST OF MEA MARKET ANALYSIS BY FUNCTIONAL PROPERTIES
  305.   6.126 REST OF MEA MARKET ANALYSIS BY SOURCE TYPE
  306.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  307.   6.128 RESEARCH PROCESS OF MRFR
  308.   6.129 DRO ANALYSIS OF HEALTHCARE
  309.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  310.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  311.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  312.   6.133 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  313.   6.134 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  314.   6.135 HEALTHCARE, BY FORMULATION TYPE, 2024 (% SHARE)
  315.   6.136 HEALTHCARE, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
  316.   6.137 HEALTHCARE, BY APPLICATION CATEGORY, 2024 (% SHARE)
  317.   6.138 HEALTHCARE, BY APPLICATION CATEGORY, 2024 TO 2035 (USD Billion)
  318.   6.139 HEALTHCARE, BY FUNCTIONAL PROPERTIES, 2024 (% SHARE)
  319.   6.140 HEALTHCARE, BY FUNCTIONAL PROPERTIES, 2024 TO 2035 (USD Billion)
  320.   6.141 HEALTHCARE, BY SOURCE TYPE, 2024 (% SHARE)
  321.   6.142 HEALTHCARE, BY SOURCE TYPE, 2024 TO 2035 (USD Billion)
  322.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  323. 7 LIST OF TABLES
  324.   7.1 LIST OF ASSUMPTIONS
  325.     7.1.1
  326.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  327.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  328.     7.2.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  329.     7.2.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  330.     7.2.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  331.     7.2.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  332.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  333.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  334.     7.3.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  335.     7.3.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  336.     7.3.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  337.     7.3.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  338.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  339.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  340.     7.4.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  341.     7.4.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  342.     7.4.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  343.     7.4.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  344.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  345.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  346.     7.5.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  347.     7.5.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  348.     7.5.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  349.     7.5.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  350.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  351.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  352.     7.6.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  353.     7.6.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  354.     7.6.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  355.     7.6.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  356.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  357.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  358.     7.7.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  359.     7.7.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  360.     7.7.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  361.     7.7.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  362.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  363.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  364.     7.8.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  365.     7.8.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  366.     7.8.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  367.     7.8.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  368.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  369.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  370.     7.9.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  371.     7.9.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  372.     7.9.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  373.     7.9.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  374.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  375.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  376.     7.10.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  377.     7.10.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  378.     7.10.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  379.     7.10.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  380.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  381.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  382.     7.11.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  383.     7.11.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  384.     7.11.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  385.     7.11.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  386.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  387.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  388.     7.12.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  389.     7.12.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  390.     7.12.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  391.     7.12.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  392.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  393.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  394.     7.13.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  395.     7.13.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  396.     7.13.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  397.     7.13.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  398.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  399.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  400.     7.14.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  401.     7.14.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  402.     7.14.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  403.     7.14.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  404.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  405.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  406.     7.15.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  407.     7.15.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  408.     7.15.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  409.     7.15.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  410.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  411.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  412.     7.16.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  413.     7.16.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  414.     7.16.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  415.     7.16.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  416.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  417.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  418.     7.17.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  419.     7.17.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  420.     7.17.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  421.     7.17.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  422.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  423.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  424.     7.18.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  425.     7.18.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  426.     7.18.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  427.     7.18.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  428.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  429.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  430.     7.19.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  431.     7.19.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  432.     7.19.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  433.     7.19.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  434.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  435.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  436.     7.20.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  437.     7.20.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  438.     7.20.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  439.     7.20.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  440.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  441.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  442.     7.21.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  443.     7.21.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  444.     7.21.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  445.     7.21.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  446.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  447.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  448.     7.22.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  449.     7.22.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  450.     7.22.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  451.     7.22.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  452.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  453.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  454.     7.23.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  455.     7.23.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  456.     7.23.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  457.     7.23.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  458.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  459.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  460.     7.24.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  461.     7.24.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  462.     7.24.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  463.     7.24.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  464.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  465.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  466.     7.25.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  467.     7.25.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  468.     7.25.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  469.     7.25.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  470.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  471.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  472.     7.26.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  473.     7.26.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  474.     7.26.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  475.     7.26.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  476.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  477.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  478.     7.27.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  479.     7.27.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  480.     7.27.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  481.     7.27.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  482.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  483.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  484.     7.28.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  485.     7.28.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  486.     7.28.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  487.     7.28.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  488.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  489.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  490.     7.29.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  491.     7.29.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  492.     7.29.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  493.     7.29.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  494.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  495.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  496.     7.30.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  497.     7.30.3 BY APPLICATION CATEGORY, 2025-2035 (USD Billion)
  498.     7.30.4 BY FUNCTIONAL PROPERTIES, 2025-2035 (USD Billion)
  499.     7.30.5 BY SOURCE TYPE, 2025-2035 (USD Billion)
  500.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  501.     7.31.1
  502.   7.32 ACQUISITION/PARTNERSHIP
  503.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Emollients
  • Humectants
  • Surfactants
  • Preservatives
  • Anti-aging Agents

Healthcare By Formulation Type (USD Billion, 2025-2035)

  • Creams and Lotions
  • Gels
  • Serums
  • Cleansers
  • Masks

Healthcare By Application Category (USD Billion, 2025-2035)

  • Skin Care
  • Hair Care
  • Oral Care
  • Makeup Products
  • Suncare

Healthcare By Functional Properties (USD Billion, 2025-2035)

  • Moisturizers
  • Anti-inflammatory Agents
  • Antioxidants
  • UV Filters
  • Exfoliants

Healthcare By Source Type (USD Billion, 2025-2035)

  • Natural Ingredients
  • Synthetic Ingredients
  • Biotech Ingredients

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions